Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05237440Recruiting
Single-arm trial, sponsored by CHU de Limoges. Primary endpoint: Salivary cortisol awakening response at Day 0. Started Apr 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05237440.